Psychemedics (NASDAQ: PMD) provides testing services for the detection of drugs of abuse through the analysis of hair samples. The company’s tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines and opiates. Its services are addressed to employers for applicant and employee testing, treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children’s drug use. For more information, visit the company’s website at www.psychemedics.com.
About CBDWire
CBDWire (CBDW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, CBDW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
For more information, visit https://www.cbdwire.com
Please see full disclaimers on the CBDWire website: http://nnw.fm/Disclaimer
CBDWire (CBDW)
Denver, CO
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
